Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(170 intermediate revisions by 6 users not shown)
Line 1: Line 1:


{| class="wikitable"
{| class="wikitable"
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
|'''Disease'''||'''Page Type'''||'''Author'''||'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Myeloproliferative Neoplasms (MPN)||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|
|
|-
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|-
|    Polycythaemia Vera  (PV)||Disease
|Gokce A. Toruner
|
|
|complete
|
|FQR
|
|
|-
|    Primary Myelofibrosis  (PMF)||Disease
|T. Niroshi  Senaratne
|
|
|complete
|
|FQR
|8/4/2020 before submission
|
|-
|    Essential  Thrombocythaemia (ET)||Disease
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|
|
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|(trainee), Daynna J.Wolff
|
|
|pending faculty review
|
|FQR
|
|
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|FQR
|
|
|
|
|-
|-
|Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|complete
| ||FQR
| ||FQR
|
|
|
|
|-
|-
|Chronic Neutrophilic Leukemia (CNL)||Disease
|    Cutaneous  Mastocytosis||Disease
| ||FQR
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|
|
|-
|    Systemic Mastocytosis||Disease
|Shashi Shetty
|
|
|complete
|
|FQR
|
|
|-
|    Mast Cell Sarcoma||Disease
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|
|
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Chronic Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|complete
|
|FQR
|
|
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|9/1/20
|pending
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|complete
|
|FQR
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Complete
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/01/2021-MS
|
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|
|
|Complete
|02/03/2021||JH / MS
|
|
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/02/2021-MS
|
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|Complete
|
|JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?  Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|Add WHO reference
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Polycythaemia Vera (PV)||Disease
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Primary Myelofibrosis (PMF)||Disease
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Essential Thrombocythaemia (ET)||Disease
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Mastocytosis||'''''Overview'''''|| ||FQR
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Cutaneous Mastocytosis||Disease
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Systemic Mastocytosis||Disease
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Mast Cell Sarcoma||Disease
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
| ||FQR
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2||'''''Overview'''''|| ||FQR
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|
|Complete
| ||JH / MS
|
|
|Need permission for figure?
|-
|-
|Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)||'''''Overview'''''|| ||FQR
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|
|Complete
| ||JH / MS
|
|
|Check reference format
|-
|-
|Chronic Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
|    Mixed Phenotype Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Juvenile Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
|    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|    Mixed-Phenotype Acute Leukemia, Not  Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic Syndromes (MDS)||'''''Overview'''''|| ||FQR
|    Acute Leukemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|Complete
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
|Acute Myeloid Leukemia (AML)  with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage  Dysplasia||Disease|| ||FQR
|Acute Myeloid Leukemia (AML)  with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|
|PENDING
|
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|Myelodysplastic syndrome with multilineage  dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease|| ||FQR
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||
|
|
|
| ||YA
|
|
|
|
|-
|-
|Myelodysplastic Syndrome (MDS), Unclassifiable||Disease|| ||FQR
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Refractory Cytopenia of Childhood||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|PENDING
|
|YA
|
|
|
|
|-
|-
| || || ||
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms||'''''Overview'''''|| ||Jennelle Hodge (JH)
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline Predisposition||'''''Overview'''''|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|Complete
|
|YA
|
|
|
|
|-
|-
|Acute Myeloid Leukaemia with Germline CEBPA Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline DDX41 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline RUNX1 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|Complete
|
|YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms with Germline ETV6 Mutation||Disease|| ||JH
|    B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Myeloid Neoplasms  with Germline GATA2 Mutation||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities||'''''Overview'''''|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Promyelocytic  Leukemia (APL) with PML-RARA||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease|| ||JH
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|Acute Myeloid  Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease|| ||JH
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease|| ||JH
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease|| ||JH
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with BCR-ABL1||Disease|| ||JH
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with Mutated NPM1||Disease|| ||JH
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with Biallelic Mutations of CEBPA||Disease|| ||JH
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease|| ||JH
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease|| ||JH
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease|| ||JH
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML), Not Otherwise Specified||'''''Overview'''''|| ||JH
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease|| ||JH
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) without Maturation||Disease|| ||JH
|    Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Maturation||Disease|| ||JH
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|Acute  Myelomonocytic Leukemia||Disease|| ||JH
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Acute Monoblastic and Monocytic Leukemia||Disease|| ||JH
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|Pure Erythroid Leukemia||Disease|| ||JH
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
| ||SP
|
|
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|    Mu Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|Complete
|5/26/2021||SP
|
|
|-
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
| ||SP
|
|
|-
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|PENDING
|
|SP
|
|
|-
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|           Primary  Amyloidosis||Disease||
|
|
|
| ||SP
|
|
|-
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Acute  Megakaryoblastic Leukemia (AMKL)||Disease|| ||JH
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Acute Basophilic  Leukemia||Disease|| ||JH
|         POEMS Syndrome||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Acute Panmyelosis  with Myelofibrosis||Disease|| ||JH
|         TEMPI Syndrome||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease|| ||JH
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Myeloid Proliferations Associated with Down Syndrome||'''''Overview'''''|| ||JH
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease|| ||JH
|    Paediatric Nodal Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|Myeloid Leukemia  Associated with Down Syndrome||Disease|| ||JH
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease|| ||JH
|    Testicular Follicular  Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Acute Leukemias of Ambiguous Lineage||'''''Overview'''''|| ||JH
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Acute Undifferentiated Leukemia||Disease|| ||JH
|    Duodenal-Type Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL) with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL), B/Myeloid, Not Otherwise Specified||Disease|| ||JH
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Mixed Phenotype  Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease|| ||JH
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|8/15/20
|PENDING
|
|SP
|
|
|
|
|-
|-
|??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||
|
|
|
|
|SP
|
|
|-
|    In Situ Mantle Cell  Neoplasia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|??Acute Leukaemias  of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease|| ||JH
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
| || || ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|PENDING
|
|Greg Corboy (GC)
|
|
|
|
|-
|-
|Precursor Lymphoid Neoplasms ||'''''Overview'''''|| ||Yassmine Akkari (YA)
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities||'''''Overview'''''|| ||YA
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2);  BCR-ABL1||Disease|| ||YA
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma with Hyperdiploidy||Disease|| ||YA
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma with Hypodiploidy||Disease|| ||YA
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|Lymphomatoid Granulomatosis||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma, BCR-ABL1-Like||Disease|| ||YA
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma with iAMP21||Disease|| ||YA
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-Lymphoblastic  Leukemia/Lymphoma, Not Otherwise Specified||Disease|| ||YA
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
|
|
|
|
|-
|-
|T-Lymphoblastic Leukemia/Lymphoma||'''''Overview'''''|| ||YA
|Primary Effusion Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|   Multicentric Castleman  Disease||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|PENDING
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|Example||Example|| ||Example
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Aggressive NK-cell Leukemia||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of  Childhood'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|  Systemic EBV-Positive  T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   Chronic Active EBV  Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Severe Mosquito Bite  Allergy||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Monomorphic  Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Intestinal T-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative  Disorders'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Lymphomatoid  Papulosis||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Primary Cutaneous  Anaplastic Large Cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Primary Cutaneous  CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of  T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Angioimmunoblastic  T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Non-Destructive  Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Polymorphic  Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative  Disorders||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||Example
| || ||
|
|
|
| ||
|
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Example||Example|| ||Example
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MLTT3
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|KMT2A
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RBM15
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MKL1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ANKRD26
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CUX1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|TET2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EZH2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|FOXP1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MYC
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|JAK2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|WT1
|DONE
|
|
|DONE
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CBL
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|NF1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|SUZ12
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ERG
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EST2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RPS14
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|RB1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MPL
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CHGA
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|CDH1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|SRSF2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|DNMT1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|PRDX2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|MN1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|SF3A1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|EP300
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|JARID2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|BRCA1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|BRCA2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||Example
|
|
|
|
|
|
|
|
|
|
|
|}
|}
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"